These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30597863)

  • 21. Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity.
    Godoy LD; Lucas JE; Bender AJ; Romanick SS; Ferguson BS
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27981795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecule inhibitors of zinc-dependent histone deacetylases.
    Wagner FF; Weїwer M; Lewis MC; Holson EB
    Neurotherapeutics; 2013 Oct; 10(4):589-604. PubMed ID: 24101253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the acetylation signaling pathway in cancer therapy.
    Dang F; Wei W
    Semin Cancer Biol; 2022 Oct; 85():209-218. PubMed ID: 33705871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.
    Bush EW; McKinsey TA
    Circ Res; 2010 Feb; 106(2):272-84. PubMed ID: 20133912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updating a Strategy for Histone Deacetylases and Its Inhibitors in the Potential Treatment of Cerebral Ischemic Stroke.
    Xu Y; Wang Q; Chen J; Ma Y; Liu X
    Dis Markers; 2020; 2020():8820803. PubMed ID: 32963637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy.
    Stratton MS; McKinsey TA
    Biochem Cell Biol; 2015 Apr; 93(2):149-57. PubMed ID: 25707943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
    Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
    Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CaMKII exacerbates heart failure progression by activating class I HDACs.
    Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
    J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functions and mechanisms of plant histone deacetylases.
    Chen X; Ding AB; Zhong X
    Sci China Life Sci; 2020 Feb; 63(2):206-216. PubMed ID: 31879846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the Expression and Role of Histone Acetylation and Deacetylation in Dental Pulp Cells.
    Yamauchi Y; Duncan HF
    Methods Mol Biol; 2023; 2588():279-293. PubMed ID: 36418694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of histone deacetylases in embryonic development.
    Dsilva P; Pai P; Shetty MG; Babitha KS
    Mol Reprod Dev; 2023 Jan; 90(1):14-26. PubMed ID: 36534913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylation of core histones in response to HDAC inhibitors is diminished in mitotic HeLa cells.
    Patzlaff JS; Terrenoire E; Turner BM; Earnshaw WC; Paulson JR
    Exp Cell Res; 2010 Aug; 316(13):2123-35. PubMed ID: 20452346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-translational modifications talk and crosstalk to class IIa histone deacetylases.
    Guttzeit S; Backs J
    J Mol Cell Cardiol; 2022 Jan; 162():53-61. PubMed ID: 34416247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics.
    Chang YC; Gnann C; Steimbach RR; Bayer FP; Lechner S; Sakhteman A; Abele M; Zecha J; Trendel J; The M; Lundberg E; Miller AK; Kuster B
    Cell Rep; 2024 Jun; 43(6):114272. PubMed ID: 38795348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of nucleosomal DNA accessibility via charge-altering post-translational modifications in histone core.
    Fenley AT; Anandakrishnan R; Kidane YH; Onufriev AV
    Epigenetics Chromatin; 2018 Mar; 11(1):11. PubMed ID: 29548294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases.
    Wang J; Feng S; Zhang Q; Qin H; Xu C; Fu X; Yan L; Zhao Y; Yao K
    Mol Neurobiol; 2023 Apr; 60(4):2330-2354. PubMed ID: 36637745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
    Wang Z; Zhao YT; Zhao TC
    Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. K-acetylation and its enzymes: overview and new developments.
    Aka JA; Kim GW; Yang XJ
    Handb Exp Pharmacol; 2011; 206():1-12. PubMed ID: 21879443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acetyl code in rheumatoid arthritis and other rheumatic diseases.
    Angiolilli C; Baeten DL; Radstake TR; Reedquist KA
    Epigenomics; 2017 Apr; 9(4):447-461. PubMed ID: 28102705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.